Vienna - Delayed Quote EUR

Marinomed Biotech AG (MARI.VI)

12.35
+0.20
+(1.65%)
At close: May 14 at 5:35:09 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,746.96
4,746.96
9,058.33
11,275.90
11,627.90
Cost of Revenue
3,766.98
3,766.98
8,077.16
9,135.20
10,203.50
Gross Profit
979.99
979.99
981.18
2,140.70
1,424.40
Operating Expense
7,933.65
7,933.65
5,980.28
7,012.80
5,549.90
Operating Income
-6,953.66
-6,953.66
-4,999.11
-4,872.10
-4,125.50
Net Non Operating Interest Income Expense
-7,897.85
-7,897.85
-1,365.16
-1,518.80
-1,568.50
Pretax Income
-15,515.50
-15,515.50
-6,361.74
-6,390.90
-5,694.20
Tax Provision
99.10
99.10
-3.50
6.80
197.10
Net Income Common Stockholders
-15,416.40
-15,416.40
-6,365.24
-6,397.70
-5,891.30
Diluted NI Available to Com Stockholders
-15,416.40
-15,416.40
-6,365.24
-6,397.70
-5,891.30
Basic EPS
-8.67
--
-4.18
-4.30
-4.00
Diluted EPS
-8.67
--
-4.18
-4.30
-4.00
Basic Average Shares
1,778.33
--
1,523.83
1,498.91
1,475.85
Diluted Average Shares
1,778.33
--
1,523.83
1,498.91
1,475.85
Total Operating Income as Reported
-7,600.98
-7,600.98
-4,996.58
-4,913.60
-4,144.70
Total Expenses
11,700.63
11,700.63
14,057.44
16,148
15,753.40
Net Income from Continuing & Discontinued Operation
-15,416.40
-15,416.40
-6,365.24
-6,397.70
-5,891.30
Normalized Income
-14,905.05
-14,905.05
-6,365.25
-6,397.70
-5,891.30
Interest Income
23.77
23.77
16.89
0.20
0
Interest Expense
7,921.62
7,921.62
1,382.04
2,508.20
1,509
Net Interest Income
-7,897.85
-7,897.85
-1,365.16
-1,518.80
-1,568.50
EBIT
-7,593.88
-7,593.88
-4,979.70
-3,882.70
-4,185.20
EBITDA
-7,180.54
-7,180.54
-4,526.58
-3,213
-3,576.30
Reconciled Cost of Revenue
3,766.98
3,766.98
8,077.16
9,135.20
10,203.50
Reconciled Depreciation
413.33
413.33
453.12
669.70
608.90
Net Income from Continuing Operation Net Minority Interest
-15,416.40
-15,416.40
-6,365.24
-6,397.70
-5,891.30
Total Unusual Items Excluding Goodwill
-664.09
-664.09
0
--
--
Total Unusual Items
-664.09
-664.09
0
--
--
Normalized EBITDA
-6,516.46
-6,516.46
-4,526.58
-3,213
-3,576.30
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-152.74
-152.74
0
0
0
12/31/2021 - 2/1/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade